Medilink North of England News 2019 Medilink NOE News 2019 | Page 14

MEDILINK’S COMMERCIAL
HEALTHCARE SECTOR PR
AGENCY
AGA NANOTECH STARTS
REVOLUTIONARY ANGLO-CHINESE
RESEARCH INTO COMBATTING
ANTIBIOTIC RESISTANCE IN POULTRY
AGA Nanotech, a British company specialising in ‘nano’ and ‘micro’
technology in the fight against antibiotic resistance, is the UK’s
lead partner in an Anglo-Chinese research study focussing on
preventing antibiotic resistance in poultry.
The study, which started in early February and is a 30-month
intensive project, will engage researchers from AGA Nanotech (AGA)
and Shanghai Veterinary Research Institute and a major Chinese
poultry company, as well as other UK based bodies like the Scottish
Rural University College and the Centre for Innovation Excellence
in Livestock (CIEL). A UK poultry company will also be joining the
consortium.
The £1m programme was born out of a call from the Department
of Health (UK) and the Ministry of Science and Technology (China),
who were seeking innovative contributions to the problem of
antimicrobial resistance (AMR) and antibiotic resistance in animal
husbandry. AGA and its partners will be working on a solution to
reduce the use of antibiotics and eliminate antibiotic resistance in
poultry, a global issue in the healthcare and food industries. The
research will aim to replace antibiotics used in poultry with AGA’s
innovative antimicrobial technology, which is an alternative to
conventional antibiotic agents.
Adrian Fellows, R&D director at AGA said: “Poultry meat is one of the
most common sources of protein in the world, and it is consumed in
all areas of the world, not just wealthy nations.
“This research project has such potential, because we believe, if
successful, we can deliver it at a price point where it can be used in
both developed and developing nations.”
Successful PR doesn’t just happen. To get it right,
you need extensive research, strategic planning
and professional implementation. Medilink’s
commercial healthcare PR agency has the sector
specific knowledge and experience to support
your organisation’s growth using cutting edge
communications tools including traditional,
digital and social media. The PR team use their
expertise and extensive contact list to raise your
profile across the healthcare sector.
Our team of PR professionals believe in an open
and integrated approach to public relations
and can happily help you to build a credible
brand and reputation for your organisation.
Medilink’s transparent business practices and
strong relation-driven client services provide
comprehensive solutions and a strong competitive
advantage to all of our members and clients.
Medilink’s PR team can provide a broad array of
services that provide solutions to organisational
challenges. We provide sector specific support
to businesses in the life sciences and healthcare
industry, and can assist in the development of
your business. With nearly 30 years combined
experience, the PR and Communications team are
here to provide outcome and not just outputs.
ǩ Strategic PR & Communication
ǩ0DUNHW$FFHVVǞ8. 2YHUVHDV
ǩ&OLHQW(QJDJHPHQW
ǩ3UHVV(QJDJHPHQWDQG/LDLVRQ
ǩ6RFLDO 'LJLWLDO&RPPXQLFDWLRQ
Get in touch today and learn more about the ways
we can help 0114 232 9292 | connect@medilink.
co.uk
“The Medilink PR team were immediately able to
understand the uniqueness of our technologies
and the important part they play in improving
patient care.”
The Scottish Rural University College, AGA’s partner institution, will
conduct trials, which will also be mirrored in China. The researchers
will be checking microorganisms and bacteria in chickens, while
making sure that the treatment is holistically beneficial to the
chickens and that they don’t show any adverse symptoms , or lose
weight gain. “They delivered with pin-point accuracy,
communications that conveyed our core
messages perfectly. I would have no hesitation
in recommending the PR team of Medilink. Truly
excellent service!”
Antibiotic resistant bloodstream infections continue to rise in
England, with an average 35% increase from 2013 to 2017. Medilink members receive a 10% discount on
Medilink PR Services.
Adrian added, “If this research is a success, it will be possible to
breed the required amount of animals without creating the health
problems caused by the excessive use of antibiotics. It would
eliminate or greatly reduce the use of antibiotics in poultry and help
eliminate residues in farm lands, ensuring safety to poultry. Positive
results of the project would be also transferable to preventing
antibiotic resistance in pork.”
Learn more at www.gamahealthcare.com
14
Lloyd Pearce, Managing Director, Trio Healthcare